MVA-BN YF (NIAID)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMVA-BN YF (NIAID)
Drug Alias NameMVA-BN based yellow fever vaccine (NIAID)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsYellow Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Bavarian Nordic A/S
Active IndicationsN/A
Inactive IndicationsYellow Fever

Other Information

ATC CodeN/A
Related LinksN/A